(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one
CAS: 1233322-09-2
Ref. 3D-IZB32209
50mg | To inquire | ||
100mg | To inquire |
Product Information
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one is a novel anticancer drug that is currently undergoing clinical trials. It has been shown to induce autophagy and apoptosis in cancer cells and may be a potential treatment for various types of cancer. The mechanism by which (E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6,6'-dichloro)-2,4'-biphenylquinoline induces autophagy is not fully understood but may involve the following: (i) activation of AMP kinase via the mTOR pathway; (ii) induction of PGC1α expression; and (iii) inhibition of AKT phosphorylation.
Mesenchymal
Chemical properties
Technical inquiry about: 3D-IZB32209 (E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.